The outcome of the cases involving two fishing companies and third-party observers could affect how the FDA engages with regulated industries, despite seeming unrelated on the surface.
The cases could potentially reshape regulatory practices by challenging the concept of Chevron deference, where courts typically defer to regulatory agencies' interpretations when laws are ambiguous.
Removing Chevron deference might shift the responsibility of decisions involving technical aspects from regulatory agencies to the courts, impacting the expertise and efficiency in decision-making processes.
[
Collection
]
[
|
...
]